These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35593784)

  • 21. Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.
    Frisk P; Sporrong SK; Ljunggren G; Wettermark B; von Euler M
    Eur J Clin Pharmacol; 2016 Jun; 72(6):747-54. PubMed ID: 26922586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triptan education and improving knowledge for optimal migraine treatment: an observational study.
    Baron EP; Markowitz SY; Lettich A; Hastriter E; Lovell B; Kalidas K; Dodick DW; Schwedt TJ;
    Headache; 2014 Apr; 54(4):686-97. PubMed ID: 24520930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice.
    Hall GC; Brown MM; Mo J; MacRae KD
    Neurology; 2004 Feb; 62(4):563-8. PubMed ID: 14981171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany.
    Hyeraci G; Gini R; Bezin J; Iannone LF; Benemei S; Lupi C; De Cesaris F; Geppetti P; Roberto G
    Headache; 2023 Feb; 63(2):222-232. PubMed ID: 36705316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triptan medication use among patients with migraine with contraindications in the US.
    Pero A; Pace A; Dhamoon MS
    Headache; 2022 Jul; 62(7):883-889. PubMed ID: 35670141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptans: low utilization and high turnover in the general population.
    Panconesi A; Pavone E; Franchini M; Mennuti N; Bartolozzi M; Guidi L; Banfi R
    Cephalalgia; 2010 May; 30(5):576-81. PubMed ID: 19732070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medication.
    Lombard L; Farrar M; Ye W; Kim Y; Cotton S; Buchanan AS; Jackson J; Joshi S
    J Headache Pain; 2020 Apr; 21(1):41. PubMed ID: 32349662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Acute Myocardial Infarction, Heart Failure, and Death in Migraine Patients Treated with Triptans.
    Ghanshani S; Chen C; Lin B; Duan L; Shen YA; Lee MS
    Headache; 2020 Nov; 60(10):2166-2175. PubMed ID: 33017476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment adherence among new triptan users: a 2-year cohort study in Taiwan.
    Chen TB; Chen YT; Fuh JL; Tang CH; Wang SJ
    J Headache Pain; 2014 Aug; 15(1):48. PubMed ID: 25117594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Migraine burden and costs in France: a nationwide claims database analysis of triptan users.
    Donnet A; Emery C; Aly S; Allaf B; Cayre F; Mahieu N; Gourmelen J; Levy P; Fagnani F
    J Med Econ; 2019 Jul; 22(7):616-624. PubMed ID: 30836035
    [No Abstract]   [Full Text] [Related]  

  • 31. Rates and predictors of starting a triptan: results from the American Migraine Prevalence and Prevention Study.
    Bigal ME; Buse DC; Chen YT; Golden W; Serrano D; Chu MK; Lipton RB
    Headache; 2010 Oct; 50(9):1440-8. PubMed ID: 20533956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute treatment of migraine: quantifying the unmet need through real-world data in Italy.
    Sacco S; Di Ciaccio S; Di Virgilio R; Pegoraro V; Ornello R
    Neurol Sci; 2024 Sep; 45(9):4427-4435. PubMed ID: 38538924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usage of triptans among migraine patients: an audit in nine GP practices.
    Williams D; Cahill T; Dowson A; Fearon H; Lipscombe S; O'Sullivan E; Rees T; Strang C; Valori A; Watson D
    Curr Med Res Opin; 2002; 18(1):1-9. PubMed ID: 11999139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis.
    Marchenko A; Etwel F; Olutunfese O; Nickel C; Koren G; Nulman I
    Headache; 2015 Apr; 55(4):490-501. PubMed ID: 25644494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions.
    Parkinson B; Gumbie M; Cutler H; Gauld N; Mumford V; Haywood P
    Value Health; 2019 Mar; 22(3):293-302. PubMed ID: 30832967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with triptan use in episodic migraine: results from the American Migraine Prevalence and Prevention Study.
    Chu MK; Buse DC; Bigal ME; Serrano D; Lipton RB
    Headache; 2012 Feb; 52(2):213-23. PubMed ID: 22413150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology, Demographics, Triptan Contraindications, and Prescription Patterns of Patients with Migraine: A German Claims Database Study.
    Gendolla A; Rauer N; Kraemer S; Schwerdtner I; Straube A
    Neurol Ther; 2022 Mar; 11(1):167-183. PubMed ID: 34837636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
    Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G
    Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry.
    Ruscheweyh R; Gossrau G; Dresler T; Freilinger T; Förderreuther S; Gaul C; Kraya T; Neeb L; Ruschil V; Straube A; Scheidt J; Jürgens TP
    J Headache Pain; 2023 Oct; 24(1):135. PubMed ID: 37817093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal Triptan Exposure and Internalising and Externalising Behaviour Problems in 3-Year-Old Children: Results from the Norwegian Mother and Child Cohort Study.
    Wood ME; Lapane K; Frazier JA; Ystrom E; Mick EO; Nordeng H
    Paediatr Perinat Epidemiol; 2016 Mar; 30(2):190-200. PubMed ID: 26525300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.